Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,905 | 5 | 74.5% |
| Honoraria | $4,300 | 1 | 18.9% |
| Travel and Lodging | $1,124 | 4 | 5.0% |
| Food and Beverage | $372.72 | 7 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $8,107 | 9 | $0 (2020) |
| CSL Behring | $4,915 | 5 | $0 (2018) |
| Global Blood Therapeutics, Inc. | $4,270 | 1 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $3,660 | 1 | $0 (2022) |
| Boehringer Ingelheim International GmbH | $1,750 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $7,930 | 2 | Global Blood Therapeutics, Inc. ($4,270) |
| 2020 | $4,300 | 2 | Merck Sharp & Dohme Corporation ($2,550) |
| 2019 | $5,557 | 8 | Merck Sharp & Dohme Corporation ($5,557) |
| 2018 | $4,915 | 5 | CSL Behring ($4,915) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2022 | AKEBIA THERAPEUTICS INC | — | Consulting Fee | Cash or cash equivalent | $3,660.00 | General |
| 08/09/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $4,270.00 | General |
| Category: Sickle Cell Disease | ||||||
| 08/14/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| 06/29/2020 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 11/20/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
| 11/20/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/16/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $59.99 | General |
| 11/16/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/16/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/15/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $297.70 | General |
| 11/15/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $138.27 | General |
| 11/15/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $135.66 | General |
| 02/09/2018 | CSL Behring | — | Honoraria | Cash or cash equivalent | $4,300.00 | General |
| 02/09/2018 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $540.58 | General |
| 02/09/2018 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $33.31 | General |
| 02/09/2018 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $29.42 | General |
| 02/09/2018 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $11.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 13 | 36 | $25,020 | $6,008 |
| 2021 | 1 | 11 | 32 | $22,240 | $5,237 |
| 2020 | 2 | 41 | 93 | $53,589 | $13,511 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 36 | $25,020 | $6,008 | 24.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 32 | $22,240 | $5,237 | 23.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 24 | 72 | $50,040 | $12,377 | 24.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 21 | $3,549 | $1,134 | 31.9% |
About Dr. Lorraine Ware, MD
Dr. Lorraine Ware, MD is a Pulmonary Disease healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659468767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorraine Ware, MD has received a total of $22,702 in payments from pharmaceutical and medical device companies, with $7,930 received in 2022. These payments were reported across 17 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($16,905).
As a Medicare-enrolled provider, Ware has provided services to 65 Medicare beneficiaries, totaling 161 services with total Medicare billing of $24,756. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Nashville, TN
- Active Since 10/09/2006
- Last Updated 08/13/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1659468767
Products in Payments
- OXBRYTA (Drug) $4,270
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Nashville
Gordon Bernard, Md, MD
Pulmonary Disease — Payments: $801,513
Dr. Otis Rickman, Do, DO
Pulmonary Disease — Payments: $298,863
Bryan Hay, M.d, M.D
Pulmonary Disease — Payments: $122,273
Vineesha Arelli, M.d, M.D
Pulmonary Disease — Payments: $31,225
Bonnie Slovis, Md, MD
Pulmonary Disease — Payments: $24,483
Dr. Victor Kha, D.o, D.O
Pulmonary Disease — Payments: $23,200